Evaluation of indium-111 as a new high photon yield gamma-emitting "physiological" platelet label.

In order to evaluate indium-111 (111In) as a "physiological" platelet label, rabbit platelets were labeled in vitro with 111In-8-hydroxyquinoline. The in vivo behavior of 111In labeled platelets was then compared with that of chromium-51 51Cr) labeled platelets in the rabbit. Several important features were evident. First, unlike 51Cr, reasonable platelet labeling efficiency could be achieved with 111In, even when the platelets were suspended in small amounts of autologous plasma. Second, the initial recovery of platelets at 20 minutes after infusion was significantly higher for the 111In labeled platelets than for 51Cr labeled platelets, providing the platelets were suspended and "washed" in plasma. Third, the mean survival time of 111In labeled platelets, as estimated using four different mathematical models, was comparable with that of 51Cr platelets. Finally, the high photon yield of gamma emitting 111In, unlike 51Cr, permits quantitative gamma camera imaging of the in vivo distribution of labeled platelets. Thus, this nuclide possesses advantages as a platelet label that will foster statistically more accurate kinetic research as well as quantitative in vivo distribution studies in humans.